SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021918
Filing Date
2020-08-13
Accepted
2020-08-13 16:49:39
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_adialpharma.htm 10-Q 406299
2 CERTIFICATION f10q0620ex31-1_adialpharma.htm EX-31.1 11873
3 CERTIFICATION f10q0620ex31-2_adialpharma.htm EX-31.2 11868
4 CERTIFICATION f10q0620ex32-1_adialpharma.htm EX-32.1 4167
5 CERTIFICATION f10q0620ex32-2_adialpharma.htm EX-32.2 4207
6 GRAPHIC image_001.jpg GRAPHIC 34512
  Complete submission text file 0001213900-20-021918.txt   2509142

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adil-20200630.xml EX-101.INS 323992
8 XBRL SCHEMA FILE adil-20200630.xsd EX-101.SCH 42100
9 XBRL CALCULATION FILE adil-20200630_cal.xml EX-101.CAL 29443
10 XBRL DEFINITION FILE adil-20200630_def.xml EX-101.DEF 133475
11 XBRL LABEL FILE adil-20200630_lab.xml EX-101.LAB 264696
12 XBRL PRESENTATION FILE adil-20200630_pre.xml EX-101.PRE 199034
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 201099985
SIC: 2834 Pharmaceutical Preparations